Impulsivity-Related Traits in Eating Disorders With Self-Harm or Suicidal Behaviour: A Systematic Review and Meta-Analysis
Abstract
Background: Although impulsivity is commonly associated with eating disorders (EDs) comorbid with self-harm, no prior reviews have investigated whether ED groups with co-occurring self-harm exhibit increased impulsivity-related traits.
Objective: This systematic review and meta-analysis synthesized the differences between ED groups with vs. without self-harm/suicidal behaviour, with respect to impulsivity-related domains.
Method: Following the PRISMA 2020 guidelines, we searched for comparative observational studies using electronic databases, reference lists, personal reference collection and requests sent to authors in the field for unpublished data. We included studies conducted from 1994 onwards that compared clinical ED groups with vs. without self-harm/suicidal behaviour on impulsivity-related domains, as assessed using questionnaires. We used a two-stage screening process conducted by independent reviewers and the Joanna Briggs Institute's tool for risk of bias assessment. Results were synthesized narratively and quantitatively, using separate random-effects meta-analyses for each impulsivity-related domain.
Results: According to meta-analytic results, clinical ED groups with self-harm/suicidal behaviour exhibited significantly increased scores on Negative Urgency (k = 10, g = 0.55), Lack of Premeditation (k = 8, g = 0.34), Lack of Perseverance (k = 8, g = 0.20) and Sensation Seeking (k = 8, g = 0.10). Only two studies assessed Positive Urgency, both reporting…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.